Abstract:Homocamptothecins (hCPTs) represent a class of new emerging antitumor agents, which contains a seven-membered beta-hydroxylactone in place of the conventional six-membered alpha-hydroxylactone ring (E ring) of camptothecins. Some novel 7-substituted hCPTs were designed and synthesized based on a newly developed synthetic route which couples ring A with ring C, E and D. Most of the synthesized compounds exhibit very high cytotoxic activity on tumor cell line A549. Some compounds, such as 9b, 91, and 9y, show broad in vitro antitumor spectrum and are more potent than topotecan. Three-dimensional quantitative structure-activity relationship (3D-QSAR) methods, CoMFA and CoMSIA, were applied to explain the structure-activity relationship (SAR) of the synthesized compounds. Furthermore, molecular docking was used to clarify the binding mode of the synthesized compounds to human DNA topoisomerase I. The important hydrophobic, base-pair stacking, and hydrogen-bonding interactions were observed between the hCPT derivatives and their receptor. The results from molecular modeling will guide the design of novel hCPTs with higher antitumor activity. (C) 2007 Elsevier Ltd. All rights reserved.

Synthesis and biological assays of 9-(acylamino) homocamptothecins as DNA topoisomerase I inhibitors

Synthesis and evaluation of 9-benzylideneamino derivatives of homocamptothecin as potent inhibitors of DNA topoisomerase I

Synthesis and biological evaluation of novel 7-acyl homocamptothecins as Topoisomerase I inhibitors

Synthesis of 9-(heteroarylmethylidene)amino derivatives of homocamptothecin with biological activities

Synthesis and biological evaluation of 7-alkenyl homocamptothecins as potent topoisomerase I inhibitors

Synthesis and biological evaluation of novel homocamptothecins conjugating with dihydropyrimidine derivatives as potent topoisomerase I inhibitors

Discovery of 7-Methyl-10-hydroxyhomocamptothecins with 1,2,3-Triazole Moiety As Potent Topoisomerase I Inhibitors

Synthesis and biological evaluation of new homocamptothecin analogs

ChemInform Abstract: Synthesis and Evaluation of 9‐benzylideneamino Derivatives of Homocamptothecin As Potent Inhibitors of DNA Topoisomerase I.

Synthesis and Pharmacological Evaluation of Novel Homocamptothecin-Dihydropyridine Derivative Conjugates As Potent Topoisomerase I Inhibitors

Topoisomerase I-mediated antiproliferative activity of 10-substituted and 12-substituted homocamptothecins

ChemInform Abstract: Synthesis and Biological Evaluation of Novel Homocamptothecins Conjugating with Dihydropyrimidine Derivatives As Potent Topoisomerase I Inhibitors.

New Homocamptothecins: Synthesis, Antitumor Activity, and Molecular Modeling.

Design, Synthesis and Biological Evaluation of Novel Homocamptothecin Analogues As Potent Antitumor Agents.

Synthesis and Cytotoxicity of Novel 20-O-linked Homocamptothecin Ester Derivatives As Potent Topoisomerase I Inhibitors

Design and One-Pot Synthesis of New 7-Acyl Camptothecin Derivatives As Potent Cytotoxic Agents

Design, Synthesis, Mechanisms of Action, and Toxicity of Novel 20(S)-Sulfonylamidine Derivatives of Camptothecin As Potent Antitumor Agents

Synthesis and Antitumor Activity of Novel 10-Amino Acids Ester Homocamptothecin Analogues

Antitumor Activities and Structure - Activity Relationship of Phosphotriester Derivatives of Homocamptothecin Based on a Semisynthetic Route

Synthesis and Antitumor Activity of Novel Soluble 9-Nitrocamptothecin Analogues

Synthesis and Antitumor Activity of Novel 10-Substituted Camptothecin Analogues.